Restenosis is a complex biological process. The promise of drug-eluting stents is that the stent scaffolding is designed to mitigate the mechanical components of the restenotic process, while the drug coating attacks the underlying biological mechanisms of restenosis.

hdl.handle.net/1765/112446
Erasmus MC: University Medical Center Rotterdam

Serruys, P., & Veldhof, S. (2001). The multi-link TETRA D™ drug-eluting coronary stent system. In Handbook of Coronary Stents, Fourth Edition (pp. 322–325). Retrieved from http://hdl.handle.net/1765/112446